
Basilea plans progression of oncology candidate lisavanbulin to targeted, biomarker-driven phase 2 study GlobeNewswire
“ovarian cancer” – Google News

Basilea plans progression of oncology candidate lisavanbulin to targeted, biomarker-driven phase 2 study GlobeNewswire
“ovarian cancer” – Google News